𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic applications of bone marrow-derived stem cells in liver transplantation for end-stage liver diseases

✍ Scribed by HaiYing Luo; YunFang Wang; Wei Kong; XueTao Pei

Book ID
107365387
Publisher
Springer
Year
2007
Tongue
English
Weight
503 KB
Volume
52
Category
Article
ISSN
1001-6538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Transplantation of urokinase-type plasmi
Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats
✍ Chao Sun; Ding-Guo Li; Yuan-Wen Chen; Ying-Wei Chen; Bao-Can Wang; Qiao-Ling Sun πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 586 KB

## Abstract ## Background Bone marrow‐derived liver stem cells (BDLSCs) are very robust cells that can differentiate into liver epithelial cells. These stem cells are promising targets for gene therapy treatment of liver diseases. Liver fibrosis results from chronic liver damage characterized by a

Endoscopic stenting of the gallbladder f
Endoscopic stenting of the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease awaiting orthotopic liver transplantation
✍ Shrestha, Roshan ;Trouillot, Thomas E. ;Everson, Gregory T. πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 168 KB

Cholecystectomy in patients with advanced cirrhosis is associated with excessive morbidity and mortality. Because open cholecystectomy in patients with Child's class C cirrhosis has a reported mortality rate as high as 83%, symptomatic gallbladder disease in patients awaiting orthotopic liver transp

Feasibility and safety of percutaneous c
Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation
✍ Babak Azarbal; Paul Poommipanit; Boris Arbit; Antoine Hage; Jignesh Patel; Miche πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

Percutaneous coronary intervention (PCI) has traditionally not been an option for patients with end-stage liver disease (ESLD) and coronary artery disease (CAD). This retrospective study was designed to demonstrate the feasibility and safety of PCI in liver transplant candidates. Patients with ESLD